Screening and Predictive Biomarkers for Down Syndrome Through Amniotic Fluid Metabolomics

This study analyzed amniotic fluid samples from pregnancies with Down syndrome and controls using targeted and untargeted metabolomics to identify differential metabolic markers. Fifty metabolites including L-glutamine, organic acids, and lipids were significantly altered in Down syndrome cases, suggesting potential biomarkers for early prenatal screening.